Keywords: UK, NICE, Sanofi, Jevtana, GlaxoSmithKline, Benlysta, ALK-Abello, Pharmalgen, Prosate cancer, Lupus, Bee and wasp stings

UK NICE negative on Sanofi’s Jevtana and GSK’s Benlysta but positive on ALK-Abello’s Pharmalgen

Article | 30 September 2011

Print This

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) this morning issued new draft guidance, which is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in